Literature DB >> 2781559

In vivo and in vitro cardiotoxicity of a gold-containing antineoplastic drug candidate in the rabbit.

G D Hoke1, R A Macia, P C Meunier, P J Bugelski, C K Mirabelli, G F Rush, W D Matthews.   

Abstract

Bis[1,2-bis(diphenylphosphino)ethane] gold(I) chloride (Au(DPPE)+2), a cytotoxic antineoplastic drug candidate, was cardiotoxic in rabbits. Intravenous administration of Au(DPPE)+2 (15 mg/kg) as a single dose produced multiple, 2- to 5-mm subendocardial and myocardial lesions, macroscopically appearing as pale tan foci. Histologically, these lesions consisted of widely scattered zones of myocardial cell necrosis and mineralization. The myocardium also contained multifocal areas of contraction band necrosis in which aggregated clumps of disorganized myofilaments were contiguous with areas of sarcoplasm which were relatively devoid of myofilaments. In a series of in vitro studies, electron microscopic examination of isolated rabbit myocytes treated with 30 microM Au(DPPE)+2 for 15 min showed evidence of mitochondrial swelling and electron translucent mitochondrial matrices. After 60 min of incubation, myocytes had mitochondria that were condensed and disrupted but the cristae had retained their tubular profiles. Isolated rabbit myocytes exposed to 30 microM Au(DPPE)+2 had significant increases in the leakage of lactate dehydrogenase, an index of cell death. Cellular ATP content in myocytes exposed to 30 microM Au(DPPE)+2 was significantly reduced by 30 min. State 4 respiration in isolated rabbit mitochondria was significantly increased by Au(DPPE)+2 (30 microM) while state 3 respiration was unaffected. Au(DPPE)+2 also caused a rapid dissipation of the mitochondrial inner membrane electrochemical potential in a concentration-dependent manner and was accompanied by a ruthenium red-sensitive calcium efflux. These data suggest that disruption of mitochondrial function, leading to uncoupling of oxidative phosphorylation, decreased ATP synthesis, and altered mitochondrial calcium homeostasis, may be a contributing factor leading to cardiac myofibril necrosis produced by Au(DPPE)+2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781559     DOI: 10.1016/0041-008x(89)90315-3

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Dilated cardiomyopathy and left bundle branch block associated with ingestion of colloidal gold and silver is reversed by British antiLewisite and vitamin E: the potential toxicity of metals used as health supplements.

Authors:  Stephen Lawrence Archer
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

2.  Binding of transition metal complexes to guanine and guanine-cytosine: hydrogen bonding and covalent effects.

Authors:  Arturo Robertazzi; James A Platts
Journal:  J Biol Inorg Chem       Date:  2005-10-14       Impact factor: 3.358

Review 3.  The medicinal applications of imidazolium carbene-metal complexes.

Authors:  Khadijah M Hindi; Matthew J Panzner; Claire A Tessier; Carolyn L Cannon; Wiley J Youngs
Journal:  Chem Rev       Date:  2009-08       Impact factor: 60.622

4.  A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling.

Authors:  Valentina Gandin; Maura Pellei; Francesco Tisato; Marina Porchia; Carlo Santini; Cristina Marzano
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

Review 5.  Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment.

Authors:  Inés Mármol; Javier Quero; María Jesús Rodríguez-Yoldi; Elena Cerrada
Journal:  Cancers (Basel)       Date:  2019-06-05       Impact factor: 6.639

Review 6.  Architecture and synthesis of P,N-heterocyclic phosphine ligands.

Authors:  Wisdom A Munzeiwa; Bernard Omondi; Vincent O Nyamori
Journal:  Beilstein J Org Chem       Date:  2020-03-12       Impact factor: 2.883

7.  Histological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]Cl.

Authors:  Ayesha Ahmed; Dalal M Al Tamimi; Anvarhusein A Isab; Abdulaziz M Mansour Alkhawajah; Mohamed A Shawarby
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.